Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 8/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.40 |
| ▸ | ITK | Q08881 | 4/20 | 0.40 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | INSR | P06213 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6414828 | 0.87 | JAK2 (0.45) | ALDH1A1SMN1; SMN2AGTR1NPC1HPGD | |
| SCHEMBL6416908 | 0.87 | ITK (0.47) | ACHEAKR1C3ITKINSR | |
| SCHEMBL6419625 | 0.85 | KIF11 (0.47) | ALDH1A1SMN1; SMN2AGTR1NPC1HPGD | |
| SCHEMBL6416231 | 0.85 | ITK (0.44) | ALDH1A1SMN1; SMN2AGTR1GAAMAPT | |
| SCHEMBL6419529 | 0.84 | SMN1; SMN2 (0.47) | ALDH1A1SMN1; SMN2AGTR1NPC1HPGD | |
| SCHEMBL6413965 | 0.84 | ACHE (0.39) | ALDH1A1SMN1; SMN2AGTR1NPC1HPGD | |
| SCHEMBL6277030 | 0.84 | RECQL (0.42) | ALDH1A1SMN1; SMN2AGTR1NPC1RAB9A | |
| SCHEMBL6273358 | 0.83 | ACHE (0.43) | ALDH1A1SMN1; SMN2AGTR1NPC1HPGD | |
| SCHEMBL6413981 | 0.82 | POLB (0.38) | ALDH1A1SMN1; SMN2AGTR1NPC1HPGD | |
| SCHEMBL6415037 | 0.82 | SMN1; SMN2 (0.39) | ALDH1A1SMN1; SMN2AGTR1NPC1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050209284-A1 | Tec kinase inhibitors | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2005-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050209284-A1 | Tec kinase inhibitors | TEC, ITK, TXK | PTGER4 2209/4885ALDH1A1 3145/4885SMN1; SMN2 3626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.